HAHN-JUN LEE M.Sc., Ph.D.
Chief Scientific OfficerHahn-Jun Lee, M.Sc., Ph.D. is a serial entrepreneur who founded or co-founded Polaryx, Epygenix Therapeutics and Focus Therapeutics, a business catalyst in the biotech-pharma industry. He also co-founded Curyx Partners, LLC, a drug development platform. Hahn-Jun has extensive experience in R&D, deal making, business development, and has consulted with several top-notch health care venture capital firms and global pharma and biotech companies, including Doman Associates, Shire Human Genetic Therapies, P&G Pharma, Melior Discovery, and CDI. He also consulted with several Korean biotechs, venture capital firms, and research institutes.
Hahn-Jun was an Assistant Professor of Biotechnology in the Department of Orthopedic Surgery, College of Physicians and Surgeons, Columbia University in the City of New York. He also worked as a Staff Scientist at the RIKEN Brain Science Institute in Japan. He obtained a B.S. in Life Science from Sogang University, Seoul, Korea. He completed his M.S. and Ph.D. in applied biotechnology in the Department of Applied Biotechnology at the University of Tokyo, Japan.